Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder
Status:
Unknown status
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the research is to study brain structure, function and chemistry of patients
with bipolar disorder who are receiving lithium, an FDA-approved treatment for bipolar mania,
in order to better understand who benefits from treatment and why they respond to
medications. Studying this may help improve treatment and outcome in patients with bipolar
disorder.